Pharmacokinetics of a fixed combination with propranolol, hydrochlorothiazide and triamterene
Felder, K.; Geissler, H.E.; Hiemstra, S.; Mutschler, E.; Schäfer, M.; Ziegler, E.
Arzneimittel-Forschung 29(11): 1746-1752
1979
ISSN/ISBN: 0004-4172 PMID: 543886 Document Number: 142307
The blood levels of propranolol, hydrochlorothiazide and triamterene, three components of a new antihypertensive combination, Dociteren, were studied in patients with mild hypertension after single dosage. The blood levels of propranolol in the combination did not differ from the blood levels obtained after a single dose of propranolol given alone.
Document emailed within 1 workday
Related Documents
Pörsti, P.; Jalonen, K.; Ryysy, L.; Toivonen, T.; Viherkoski, M. 1981: Antihypertensive action of drug combination: Timolol, hydralazine, hydrochlorothiazide and triamterene Annals of Clinical Research 13(1): 6-10Mauro, B.; Savagnone, E. 1979: The combination of propranolol, hydrochlorothiazide and spironolactone in the treatment of essential arterial hypertension Bollettino Della Societa Italiana di Cardiologia 24(2): 189-196
Schwartz, F.N.; Tiffany, J. 1981: Timolol maleate and hydrochlorothiazide in control of essential hypertension: use of a fixed combination for once-a-day administration Journal of the American Osteopathic Association 80(9): 590-594
Salvadeo, A.; Villa, G.; Segagni, S.; Moroni, G.; Poggio, F. 1988: Validity of a fixed atenolol/hydrochlorothiazide/amiloride combination (100/25/2.5 mg) in the therapy of essential arterial hypertension Minerva Cardioangiologica 36(3): 109-113
Antonicelli, R.; Raffaelli, S.; Bossini, A.; Paciaroni, E.; Zingaretti, P.; Botta, G.F. 1989: Evaluation of the efficacy and tolerability of a fixed dose combination of captopril (CPT) 50 mg and hydrochlorothiazide (HCTZ) 15 mg in the elderly Rivista Europea Per le Scienze Mediche e Farmacologiche 11(2): 155-161
Heesen, W.F.; Beltman, F.W.; Smit, A.J.; May, J.F.; de Graeff, P.A.; Havinga, T.K.; Schuurman, F.H.; van der Veur, E.; Meyboom-de Jong, B.; Lie, K.I. 1998: Effect of quinapril and triamterene/hydrochlorothiazide on cardiac and vascular end-organ damage in isolated systolic hypertension Journal of Cardiovascular Pharmacology 31(2): 187-194
Arndts, D.; Doevendans, J.; Arendt, G.; Rippen, G. 1981: Pharmacokinetics of clonidine and chlorthalidone following subacute administration of a fixed combination compared with a sustained release formulation of clonidine alone Arzneimittel-Forschung 31(11): 1954-1957
Molling, J.; Leuschner, U.; Meyer, F.P.; Walther, H. 1986: Thin layer chromatographic determination of talinolol, propranolol and triamterene in urine: compliance evaluation of hypertensive patients Die Pharmazie 41(4): 301-302
Vanprapar, N.; Cressey, T.R.; Chokephaibulkit, K.; Muresan, P.; Plipat, N.; Sirisanthana, V.; Prasitsuebsai, W.; Hongsiriwan, S.; Chotpitayasunondh, T.; Eksaengsri, A.; Toye, M.; Smith, M.E.; McIntosh, K.; Capparelli, E.; Yogev, R. 2010: A chewable pediatric fixed-dose combination tablet of stavudine, lamivudine, and nevirapine: pharmacokinetics and safety compared with the individual liquid formulations in human immunodeficiency virus-infected children in Thailand Pediatric Infectious Disease Journal 29(10): 940-944
MacGregor, G.A.; Markandu, N.D.; Smith, S.J.; Sagnella, G.A. 1985: Captopril: contrasting effects of adding hydrochlorothiazide, propranolol, or nifedipine Journal of Cardiovascular Pharmacology 7(Suppl 1): S82-S87
Prisant, L.M.; Carr, A.A.; Nelson, E.B.; Winer, N.; Velasquez, M.T.; Gonasun, L.M. 1989: Isradipine vs propranolol in hydrochlorothiazide-treated hypertensives. a multicenter evaluation Archives of Internal Medicine 149(11): 2453-2457
Fager, G.; Berglund, G.; Bondjers, G.; Elmfeldt, D.; Lager, I.; Olofsson, S.O.; Smith, U.; Wiklund, O. 1983: Effects of anti-hypertensive therapy on serum lipoproteins. Treatment with metoprolol, propranolol and hydrochlorothiazide Artery 11(4): 283-296
McCorvey, E.; Wright, J.T.; Culbert, J.P.; McKenney, J.M.; Proctor, J.D.; Annett, M.P. 1993: Effect of hydrochlorothiazide, enalapril, and propranolol on quality of life and cognitive and motor function in hypertensive patients Clinical Pharmacy 12(4): 300-305
Laher, M.S.; Mulkerrins, E.; Hosie, J.; Connell, P.A.; Smith, R.P.; Swaisland, A.J. 1991: The effects of age and renal impairment on the pharmacokinetics of co-administered lisinopril and hydrochlorothiazide Journal of Human Hypertension 5(Suppl 2): 77-84
Miller, E. 1991: Introduction to lisinopril-hydrochlorothiazide combination Journal of Human Hypertension 5 Suppl. 2: 49-51
Nedogoda, S.V. 2011: Combination of perindopril and amlodipine as optimal basis for realization of desirable clinical effects in the treatment of arterial hypertension with fixed drug combination Kardiologiia 51(1): 112-120
1982: Comparison of propranolol and hydrochlorothiazide for the initial treatment of hypertension. II. Results of long-term therapy. Veterans Administration Cooperative Study Group on Antihypertensive Agents JAMA 248(16): 2004-2011
Heim, J.; Dewailly, P.; Jaillard, J. 1977: Hyperkalemia caused by hyporeninism: role of the hydrochlorothiazide-amiloride combination Lille Medical: Journal de la Faculte de Medecine et de Pharmacie de l'Universite de Lille 22(10): 793-797
Bolzano, K.; Krempler, F.; Sandhofer, F. 1984: A combination of methyldopa, hydrochlorothiazide and amiloride in the treatment of essential hypertension Acta Medica Austriaca 11(2): 49-53
Da Cunha, G.P.; Albanesi, F.M.; Wajngarten, M.; Cantarelli, E.L. 1983: Treatment of arterial hypertension with a combination of hydrochlorothiazide and hydrochloride amiloride Arquivos Brasileiros de Cardiologia 40(5): 353-356